Skip to content

Clinical trials

Completed Phase 1/2 Nasopharyngeal Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Phase: Phase 1/2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20091
20101
20121
20152
20161
20181
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alberta Health services1
Fuda Cancer Hospital, Guangzhou1
Jiangsu Cancer Institute & Hospital1
National University Hospital, Singapore1
RAPT Therapeutics, Inc., a member of the GSK plc group of companies1
Shanghai Junshi Bioscience Co., Ltd.1
Shanghai Proton and Heavy Ion Center1
Taizhou Hospital1
University of Washington1
West China Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma12
Squamous Cell Carcinoma of Head and Neck3
Nasopharyngeal Neoplasms2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Head and Neck Neoplasms1
Lymphoma1
Salivary Gland Neoplasms1
Stomatitis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.